Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
US Army
Baxter
Healthtrust
Daiichi Sankyo
Citi
Cantor Fitzgerald
Johnson and Johnson

Generated: May 23, 2018

DrugPatentWatch Database Preview

ULTRAVIST 150 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ultravist 150 patents expire, and what generic alternatives are available?

Ultravist 150 is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in ULTRAVIST 150 is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.
Drug patent expirations by year for ULTRAVIST 150
Pharmacology for ULTRAVIST 150
Synonyms for ULTRAVIST 150
1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-N-methylbenzene-1,3-dicarboxamide
1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-N-methyl-
1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((methoxyacetyl)amino)-N-methyl-2,4,6-triiodo-
334I073
73334-07-3
AB00513942
AC-535
AC1L1GLH
AC1Q4PC5
AK468747
AKOS025402129
AN-15741
BAY 86-4877
BAY86-4877
BC200690
BPBio1_001039
BRN 7085608
BSPBio_000943
C-23779
C18H24I3N3O8
CAS-73334-07-3
CC-29577
CCG-220872
CHEBI:63578
CHEMBL1725
CS-0013103
D01893
D07GNP
DB09156
DGAIEPBNLOQYER-UHFFFAOYSA-N
DR003567
DSSTox_CID_3163
DSSTox_GSID_23163
DSSTox_RID_76898
DTXSID0023163
EINECS 277-385-9
FT-0627283
HMS1570P05
HMS2097P05
HMS2233O23
HMS3370M05
HY-B1362
I661
iopromid
Iopromida
Iopromida [INN-Spanish]
iopromide
Iopromide (JAN/USP/INN)
Iopromide [USAN:INN:BAN]
Iopromide [USAN:USP:INN:BAN]
Iopromide for system suitability 1, European Pharmacopoeia (EP) Reference Standard
Iopromide for system suitability 2, European Pharmacopoeia (EP) Reference Standard
Iopromide, analytical standard
Iopromide, European Pharmacopoeia (EP) Reference Standard
Iopromide, United States Pharmacopeia (USP) Reference Standard
Iopromidum
Iopromidum [INN-Latin]
LS-29729
MLS002154045
MolPort-005-932-395
N-(2,3-dihydroxypropyl)-3-[(2,3-dihydroxypropyl)(methyl)carbamoyl]-5-[(1-hydroxy-2-methoxyethylidene)amino]-2,4,6-triiodobenzene-1-carboximidic acid
N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-methylisophthalamide
N,N'-Bis(2,3-Dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl-1,3-benzenedicarboxamide
n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-n-methylisophthalamide
N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-5-{[(methyloxy)acetyl]amino}benzene-1,3-dicarboxamide
N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N1-methylisophthalamide
N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
NCGC00016923-01
NCGC00179367-01
NCGC00179367-03
OR207728
OR334484
Prestwick0_000872
Prestwick1_000872
Prestwick2_000872
Prestwick3_000872
Proscope
Proscope (TN)
SCHEMBL24546
SH-L-414C
SHL 414C
SMR001233368
SPBio_002864
SR-01000841262
SR-01000841262-2
Tox21_110684
Tox21_110684_1
Ultrakon
Ultravist
Ultravist (pharmacy bulk)
Ultravist (TN)
Ultravist 240
Ultravist 300
Ultravist 300 In Plastic Container
Ultravist 370
ZK 35760
ZK-35760

US Patents and Regulatory Information for ULTRAVIST 150

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare ULTRAVIST 150 iopromide INJECTABLE;INJECTION 020220-004 May 10, 1995 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
McKesson
Accenture
QuintilesIMS
McKinsey
Teva
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.